International Biotechnology Trust’s Albireo Pharma Inc ALBO Stock Holding History

International Biotechnology Trust’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-38,000	Closed	-$820K	–	69
2022 Q4	$820K	Buy	38,000 +21,907	+136%	+$463K	0.25%	54
2022 Q3	$312K	Buy	+16,093	New	+$333K	0.1%	64

Other funds holding ALBO

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

International Biotechnology Trust's ALBO Position: Q1 2023 in Review

International Biotechnology Trust sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 38,000 shares — an estimated $820K sold.

International Biotechnology Trust first reported a position in ALBO in Q3 2022 and held it in 2 quarters. The position peaked at $820K in Q4 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

International Biotechnology Trust reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
International Biotechnology Trust sold 38,000 Albireo Pharma Inc shares in Q1 2023, an estimated $820K.
International Biotechnology Trust first reported a position in Albireo Pharma Inc in Q3 2022 and held it in 2 quarters.
International Biotechnology Trust's Albireo Pharma Inc position peaked at $820K in Q4 2022.
3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on International Biotechnology Trust's 13F filing for Q1 2023, filed 18 May 2023.